Conflicting COVID developments kept the major indices grounded for a second straight session.
Pfizer (PFE, +0.8%) and BioNTech (BNTX, +4.0%) on Wednesday announced a complete set of trial data showing that their COVID-19 vaccine is 95% effective (better than the 90%-plus efficacy reported from partial data last week). Later Wednesday, BioNTech CEO Ugur Sahin told CNN that the companies would file for an Emergency Use Authorization from the U.S. Food and Drug Administration on Friday.
That fueled market gains early on, but investors' focus shifted to America's escalating pandemic situation.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The U.S. set a new daily caseload record with 155,000 reported Tuesday, and yesterday's 1,707 deaths were the highest since May 14, according to Johns Hopkins University data. Municipalities nationwide have begun implementing curfews, closures and other measures, and a new stimulus bill remains far out of sight.
The Dow Jones Industrial Average, which began the day solidly higher, dipped into the close, finishing with an 1.2% decline to 29,438.
Other action in the stock market today:
- The S&P 500 also dropped 1.2% to 3,567.
- The Nasdaq Composite lost 0.8% to 11,801.
- The Russell 2000 fell 1.3% off yesterday's record close, finishing at 1,769.
- U.S. crude oil futures closed 0.9% higher to settle at $41.80 per barrel.
- Gold futures finished lower again, settling at $1,873.90 per ounce, a 0.6% decline.
- Target (TGT) climbed 2.3% after the company crushed analyst expectations for its third quarter. Record adjusted profits of $2.79 per share were more than double year-over-year and beat expectations for $1.60. "The sustainability of its pandemic-driven surge in sales and earnings becomes the key question, particularly given uncertainty regarding future stimulus and waning retail sales growth," writes CFRA's Garrett Nelson (Hold).
- Boeing (BA, -3.2%), like the Dow, started the day higher but finished with losses. But it was still a good day for the aircraft manufacturer, as the Federal Aviation Administration provided a green light for its troubled 737 Max to return to the skies.
A Rotation? Maybe. A Swift Rotation? Absolutely Not.
We've discussed in recent weeks the idea that the market appears to be rotating away from certain stocks and toward others. There's the rotation from growth stocks into value stocks. And the rotation away from sectors such as technology and into the likes of industrials and financials.
Whether or not this rotation continues is up in the air. But it's not just a flip of the switch.
"(Investors) need to remember internal sector and industry rotations are frequently lumpy with entry/exit points that are very difficult to time," says Scott Knapp, chief market strategist at CUNA Mutual Group. "Staying diversified throughout is still the best play for long-term investors."
Fortunately, it has never been easier or cheaper to get wide stock (and bond) exposure. These 10 rock-solid mutual funds don't have too much in common – some are broad-market plays, others are narrow sector bets and still others deliver fixed income – but they all share attributes that matter: low costs, dependable management and top-tier performance. Check them out.
Kyle Woodley was long BA as of this writing.
-
A Lesson From the School of Rock About the MarketsIt's hard to hold your nerve during a downturn, but next time the markets take a tumble, remember this quick rock 'n' roll tutorial and aim to stay invested.
-
I retired at 65 with $7.8 million and feel like I over-saved. My 40-something son is on the same path. Should I tell him to reconsider?We ask financial experts for advice.
-
S&P 500 Sees New Highs on Shutdown Day: Stock Market TodayMost of its components were in the red, but the S&P 500 Index still managed to hit a new intraday all-time high.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-
If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
Dow Adds 300 Points, Ends Losing Streak: Stock Market TodayThe Dow, the S&P 500 and the Nasdaq head into the weekend on high notes after posting gains for the first time since Monday.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
President Trump Makes Markets Move Again: Stock Market TodayThe White House is moving ahead with plans to reshape the Federal Reserve and to buy shares in more sectors and stocks.
-
Tech Sells Off While Trump Stirs the Fed: Stock Market TodayWe've reached another important part of earnings season, though markets remain captivated by the president, the Fed, and interest rate policy.
